急性冠状动脉封闭性心肌梗塞:STEMI标准的表现和不断发展的替代方法
Ryan Tudino1, Edward Richardson1, Jessica M Gonzalez1
1Department of Internal Medicine, Rhode Island Hospital, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island, USA.
Trends in cardiovascular medicine
|October 21, 2025
概括
急性冠状动脉综合征 (ACS) 的管理不同基于ST升高心肌梗塞 (STEMI) 标准. 非STEMI ACS中的"STEMI-等价物"可能表明急性冠状动脉封闭,需要进一步调查以及时进行再输血.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 临床诊断 临床诊断 临床诊断
背景情况:
- 急性冠状动脉综合征 (ACS) 包括STEMI,NSTEMI和UA,主要是由动脉血症和冠状动脉封闭引起的.
- 目前的指导方针规定了ACS的冠状动脉血管造影时间变化,STEMI患者优先进行立即导管注射.
- 尽管很大一部分患者患有急性冠状动脉封闭 (ACO),但NSTEMI患者通常会延迟输血.
研究的目的:
- 在NSTEMI ACS中审查有关急性冠状动脉封闭性心肌梗塞 (ACOMI) 的文献.
- 检查NSTEMI中的"STEMI等价物"的诊断和临床意义.
- 探索在NSTEMI ACS中改善风险分层的策略.
主要方法:
- 在NSTEMI ACS.中对ACOMI和"STEMI等价物"的文献综述.
- 分析当前的诊断标准和指导方针建议.
- 讨论修订标准和预测工具的可能性.
主要成果:
- 在NSTEMI ACS患者中,存在大量的ACO.CO.患者.
- "STEMI等价物"是专家陈述中公认的高风险特征,但未在指导方针中正式采用.
- 目前的诊断和选策略可能无法最佳地识别所有需要紧急再输血的NSTEMI患者.
结论:
- "STEMI等价物"是NSTEMI ACS.中进一步研究的关键领域.
- 需要修订诊断标准和预测工具,以更好地分层NSTEMI ACS患者进行再注射治疗.
- 优化NSTEMI ACS的分组可以通过识别患有ACO的患者来改善结果.
相关概念视频
Acute Coronary Syndrome I: Introduction
794
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
794
Acute Coronary Syndrome IV: Interprofessional Care
216
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
216
Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
351
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
351
Acute Coronary Syndrome V: Nursing Management
265
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
265
Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212


